Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
11.9%
% of XBI's 119 holdings also in IBRN
35.0%
% of IBRN's 58 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
NEUROCRINE BIOSCIENCES INC | 2.6% | 4.5% | 2.6% |
|
BIOGEN IDEC INC | 2.3% | 3.9% | 2.3% |
|
SAREPTA THERAPEUTICS INC | 1.3% | 2.6% | 1.3% |
 |
ALKERMES PLC | 1.0% | 3.9% | 1.0% |
|
SCHOLAR ROCK HOLDING CORP. | 0.9% | 4.3% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to IBRN
|
NATERA INC | 2.8% |
|
VERTEX PHARMACEUTICALS INC | 2.7% |
|
INSMED INC | 2.7% |
|
ALNYLAM PHARMACEUTICALS INC | 2.7% |
|
UNITED THERAPEUTICS CORP | 2.6% |
|
GILEAD SCIENCES INC | 2.5% |
|
EXACT SCIENCES CORP | 2.5% |
|
AMGEN INC | 2.5% |
|
INCYTE CORP | 2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.3% |
XBI Underweight Relative to IBRN
 |
ARGENX SE ADR | -5.0% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -5.0% |
|
CATALYST PHARMACEUTICAL PART | -4.5% |
|
SUPERNUS PHARMACEUTICALS INC | -4.2% |
|
PTC THERAPEUTICS INC | -3.8% |
|
ACADIA PHARMACEUTICALS INC | -3.4% |
|
DENALI THERAPEUTICS INC. | -3.4% |
|
SCHOLAR ROCK HOLDING CORP. | -3.4% |
|
ALKERMES PLC | -2.9% |
|
INTEGRA LIFESCIENCES HOLDING | -2.7% |